BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34662672)

  • 1. Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment.
    Yang Y; Wu H; Liu B; Liu Z
    Adv Drug Deliv Rev; 2021 Dec; 179():114004. PubMed ID: 34662672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
    Sia CS; Lim HP; Tey BT; Goh BH; Low LE
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-responsive dynamic nanoassemblies for targeted imaging, therapy and microenvironment manipulation.
    Low LE; Wu J; Lee J; Tey BT; Goh BH; Gao J; Li F; Ling D
    J Control Release; 2020 Aug; 324():69-103. PubMed ID: 32423874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 6. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
    Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
    Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
    Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
    Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment.
    Malla RR; Kamal MA
    Curr Med Chem; 2021; 28(28):5674-5698. PubMed ID: 33297907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoplatform-based cascade engineering for cancer therapy.
    Chen J; Zhu Y; Wu C; Shi J
    Chem Soc Rev; 2020 Dec; 49(24):9057-9094. PubMed ID: 33112326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment Stimuli-Responsive Fluorescence Imaging and Synergistic Cancer Therapy by Carbon-Dot-Cu
    Sun S; Chen Q; Tang Z; Liu C; Li Z; Wu A; Lin H
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):21041-21048. PubMed ID: 32914924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive Smart Liposomes in Cancer Targeting.
    Jain A; Jain SK
    Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors.
    Soltani M; Souri M; Moradi Kashkooli F
    Sci Rep; 2021 Sep; 11(1):19350. PubMed ID: 34588504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.
    Dai Y; Xu C; Sun X; Chen X
    Chem Soc Rev; 2017 Jun; 46(12):3830-3852. PubMed ID: 28516983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics.
    Wei D; Sun Y; Zhu H; Fu Q
    ACS Nano; 2023 Dec; 17(23):23223-23261. PubMed ID: 38041800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine from amphiphilizedprodrugs: Concept and clinical translation.
    Xiang J; Liu X; Yuan G; Zhang R; Zhou Q; Xie T; Shen Y
    Adv Drug Deliv Rev; 2021 Dec; 179():114027. PubMed ID: 34732344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
    Kwon S; Ko H; You DG; Kataoka K; Park JH
    Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 'dual-key-and-lock' drug carriers for imaging and improved drug release.
    Gao H; Zhang Y; Chi B; Lin C; Tian F; Xu M; Wang Y; Xu Z; Li L; Wang J
    Nanotechnology; 2020 Oct; 31(44):445102. PubMed ID: 32668418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.